ASPHALION´S COVID-19 CONTRIBUTION: 17 PROJECTS

Coinciding with the end of many restrictions related to the pandemic announced by local authorities this week, we would like to look back and put in perspective and thank our team for their hard work.

Coinciding with the end of many restrictions related to the pandemic announced by local authorities this week, we would like to look back and put in perspective and thank our team for their hard work.
October 22, 2021

Coinciding with the end of many restrictions related to the pandemic announced by local authorities this week, we would like to look back and put in perspective and thank our team for their hard work.

With their effort and expertise, they have contributed to the development of all these projects in the fight against COVID-19. We are proud to have collaborated in 17 projects, but prouder even of the high level of commitment and energy shown by Asphalion’s team.

During the pandemic we created specific working groups, aimed at giving regulatory support to manufacturers, institutions, and European consortia. At the beginning of the pandemic, we even offered advise free of charge in order to contribute to the urgency of the onset.

We dream about being a global reference and driving force into the evolution of the healthcare sector, offering the best environment for the individual and collective growth of our team and clients.

See Asphalion´s contributions to the fight against COVID-19 in more detail here:

COVID-19: Asphalion: 17 projects

For further information you can contact us at: [email protected]

 

 

Search News & Events

  • Filter by category

Share

Related news and events

EVENT | DIA RAPS Regulatory Policy Forum

Many key takeaways and highlights from the DIA RAPs Regulatory Policy Forum!! Capitalizing on the success of their joint collaboration this past January for 2024 Combination Products in the EU, DIA and the Regulatory Affairs Professionals Society (RAPS) are coming together once again to produce the 2024 Regulatory Policy Forum.
Designed specifically for regulatory policy leaders, senior decision makers, and regulators across the pharmaceutical community, this summit will explore the new EU pharmaceutical legislation and how it will shape the future of the pharmaceutical arena—including research, development and manufacturing—in Europe for decades to come.

For further information

If you are interested in our services, or wish to get in touch for a general enquiry, please contact us for more information.

Fill the form and we will contact you as soon as possible.

You can also follow us on:

Schedule a Free Meeting

Schedule here a free 30-minutes meeting with one of our consultants and tell us about your project, challenges or doubts. 

We will be happy to assist you!

Schedule a meeting